The virus-like particles (VLP’s) market is projected to reach US$ 7,858.82 million by 2028 from US$ 4,601.84 million in 2021; it is expected to grow at a CAGR of 7.9% from 2021 to 2028.
The commercialization of virus-like particles -based vaccines against human and animal viruses, vigorous research and development activities for the development of virus-like particles -based viral vaccines, and virus-like particles emerging as a reliable immunotherapy platform for allergic diseases are the key driving factors responsible for the overall market growth. However, technical challenges related to the design, purification, and storage of eVLPs impede the overall market growth. Additionally, complexities associated with the manufacturing of virus-like particles vaccines, coupled with excess cost and time requirement of processes (such as downstream processing for virus-like particles -based vaccines), further limit the global market growth. Furthermore, virus-like particles -based therapeutics intended for topical and emerging viral diseases as well as cancer are still under development, which is posing lucrative opportunities for the overall market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Virus-Like Particles Market: Strategic Insights
Market Size Value in US$ 4,601.84 million in 2021 Market Size Value by US$ 7,858.82 million by 2028 Growth rate CAGR of 7.9% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Virus-Like Particles Market: Strategic Insights
| Market Size Value in | US$ 4,601.84 million in 2021 |
| Market Size Value by | US$ 7,858.82 million by 2028 |
| Growth rate | CAGR of 7.9% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
North America is likely to continue its dominance in the virus-like particles market during 2021–2028. The US holds the largest share of the market in North American and is expected to continue this trend during the forecast period. This is primarily attributed to commonly observed susceptibility of people toward viral infections, such as viral influenza caused by different variants. Moreover, continuous R&D activities required for the manufacturing of live attenuated vaccines compels biopharmaceutical companies to opt for virus-like particle’s, which further supports the market growth.
Lucrative Regions for Virus-Like Particles (VLPs) Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Commercialized virus-like particles based Vaccines drives the overall market growth
According to a report published by the Frontiers Media S.A., the first virus-like particles -based vaccine was designed to combat a deadly virus, Hepatitis B, and virus-like particles -based vaccines have produced promising safety results compared to traditional vaccines. The first commercialized virus-like particles -based vaccine was against HBV. Also, the commercial anti-HBV vaccines, namely, "Engerix" manufactured by GlaxoSmithKline and "Recombivax HB" manufactured by Merck & Co. were approved in 1980, and they were all virus-like particles. The next commercially available virus-like particles -based vaccine was "Gardasil," which was approved in 2006 to prevent human papillomavirus (HPV) infections. Further, virus-like particles are also used in veterinary medicine. The first commercially available veterinary vaccine based on virus-like particles was proven effective against porcine circovirus type 2 (PCV2).
The role of virus-like particles in the development of immunotherapy products against allergic diseases further stimulates the overall market growth. virus-like particles are used in the treatment of allergic rhinitis, asthma, and dust mite reactions. The aforementioned factors drive the growth of the overall virus-like particles market exponentially. virus-like particles vaccines have shown rapid immune response with mild skin reaction as side effects.
Product Type-Based Insights
Based on product type, the virus-like particles market is segmented as hepatitis, cancer/HPV, and Gaucher disease. The hepatitis segment would account for a large market share during 2021–2028. The Frontiers S.A. report pinpoints that hepatitis C virus (HCV) infects 2% of the global population, and it is a leading cause of liver disease and liver transplantation. This medical threat can partially be addressed by the introduction of new antiviral therapies. For example, a vaccine with 50–80% efficacy, targeting high-risk intravenous drug users, dramatically reduces HCV incidence among the population. Therefore, virus-like particles represent a safe and highly immunogenic vaccine delivery platform that induces an adaptive immune response. Several virus-like particles -based vaccines are currently in clinical trials; however, licensed VLP vaccines for HBV and HPV have been in use since long. Thus, virus-like particles based vaccines have proved their effectiveness relating to favorable immunological characteristics and making them one of the promising HCV vaccines.
Virus-Like Particles (VLPs) Market, by Product Type – 2020 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Source-Based Insights
Based on source, the virus-like particles (VLP’s) market is segmented into yeast, insect cell, plant, and others. The yeast segment holds a considerable market share and is projected to continue the similar trend during the forecast period. virus-like particles are produced by heterologous expression systems, involving yeast or baculovirus, as well as plants and bacteria. Safety of virus-like particles -based vaccines produced using yeast expression systems contributes to the growth of the market for the yeast-based virus-like particles.
Application -Based Insights
By application, the virus-like particles market is segmented as vaccines and therapeutics. The vaccines segment would hold a considerable share of the market in 2021, and it is likely to continue its dominance in the market during the forecast period as well. Vaccination is considered as one of the most effective ways of controlling pathogens and preventing diseases, both in humans and animals. virus-like particles -based vaccines represent one of the most appealing approaches owing to their intrinsic immunogenic properties and safety. For example, virus-like particles are noninfectious, multimeric antigens having a particulate structure, suitable for the induction of safe and efficient humoral and cellular immune response. Apart from that, virus-like particles vaccines have proved their effectiveness in veterinary field. virus-like particles are only composed of one or more structural proteins without presence of genomes of native viruses and non-ability for self-replication in cells. However, virus-like particles containing either monovalent or multivalent antigen can be produced in compliance with the requirement for serological surveillance, the utility of virus-like particles vaccines proves promising in the veterinary field. One such example of utilizing virus-like particles vaccines under Differentiating Infected from Vaccinated Animals (DIVA) vaccination strategies against animal diseases.
Companies operating in the virus-like particles (VLPs) market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.
Virus-Like Particles (VLPs) Market – by Product Type
- Hepatitis
- Cancer/HPV
- Gaucher Disease
Virus-Like Particles (VLPs) Market – by Source
- Yeast
- Insect Cell
- Plant
- Others
Virus-Like Particles (VLPs) Market – by Application
- Vaccines
- Therapeutics
Virus-Like Particles (VLPs) Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Dynavax Technologies
- Sanofi
- Wantai BioPharm
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- VBI Vaccines Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Source, Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global virus-like particles (VLP's) market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for virus-like particles (VLP’s). The US is estimated to hold the largest share in the virus-like particles (VLP’s) market during the forecast period. Presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for VLP’s accounting fastest growth of the region during the coming years.
Answer: - Merck & Co., Inc., GlaxoSmithKline plc., Pfizer Inc., Dynavax Technologies, Sanofi, Wantai BioPharm, Serum Institute of India Pvt. Ltd., BHARAT BIOTECH, LG Chem, and VBI Vaccines Inc. are among the leading companies operating in the global Virus-Like Particles (VLP's) market
The vaccine segment dominated the global virus-like particles (VLP's) market and accounted for the largest revenue of 4,558.08 Mn in 2021.
Based on product-type, hepatitis segment took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.
American Society for Microbiology defines virus-like particles (VLP's) as non-infectious multiprotein structure that are engineered to self-assemble from viral structure proteins. VLP technology proves to be a very powerful tool involved in development of vaccines. Several VLP based vaccines exist in the global market involving hepatitis B virus and human papillomavirus.
Commercial VLP based vaccines against human and animal viruses, intensive research and development activities for the development of VLPs based vaccines effective against viral infections, and VLPs acting as the best immunotherapy platform for allergic diseases are the key driving factors responsible for the overall market growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Virus-like Particles Market – By Product Type
1.3.2 Global Virus-like Particles Market – By Source
1.3.3 Global Virus-like Particles Market – By Application
1.3.4 Global Virus-like Particles Market – By Geography
2. Global Virus-like Particles Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Virus-like Particles Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Virus-like Particles Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Prevalence of Infectious Viral Diseases
5.1.2 Widening Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2 Market Restraints
5.2.1 Availability of Alternative Technologies for Viral Vaccine Production
5.3 Market Opportunities
5.3.1 Potential Applications in Therapeutics and Diagnostics
5.4 Future Trends
5.4.1 Continuous Demand for Innovative and Effective Products
5.5 Impact Analysis
6. Virus-like Particles Market– Global Analysis
6.1 Global Virus-like Particles Market Revenue Forecast and Analysis
6.2 Global Virus-like Particles Market, By Geography - Forecast and Analysis
7. Virus-like Particles Market Revenue and Forecasts To 2028– by Product Type
7.1 Overview
7.2 Global Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3 Hepatitis
7.3.1 Overview
7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Cancer/ Human Papillomavirus (HPV)
7.4.1 Overview
7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Gaucher Disease
7.5.1 Overview
7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
8. Virus-like Particles Market Revenue and Forecasts To 2028 – By Source
8.1 Overview
8.2 Global Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3 Yeast
8.3.1 Overview
8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Plant
8.4.1 Overview
8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Insect Cell
8.5.1 Overview
8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
9. Virus-like Particles Market Revenue and Forecasts To 2028 – By Application
9.1 Overview
9.2 Global Virus-like Particles Market Share, by Treatment, 2021 & 2028 (%)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10. Virus-like Particles Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Virus-like Particles Market
10.1.1 Overview
10.1.2 North America: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.1.3 North America: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)
10.1.4 North America Virus-Like Particles Market, by Source, 2019–2028 (US$ Mn)
10.1.5 North America: Virus-like Particles Market, by Application, 2019–2028 (US$ Mn)
10.1.6 North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.1.6.1.1 Overview
10.1.6.1.2 US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.1.6.1.3 US: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)
10.1.6.1.4 US: Virus-like Particles Market, by Source, 2019–2028 (US$ Mn)
10.1.6.1.5 US: Virus-like Particles Market, by Application, 2019–2028 (US$ Mn)
10.1.6.2 Canada: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.1.6.2.3 Canada: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)
10.1.6.2.4 Canada: Virus-like Particles Market, by Source, 2019–2028 (US$ Mn)
10.1.6.2.5 Canada Virus-Like Particles Market, by Application, 2019–2028 (US$ Mn)
10.1.6.3 Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.1.6.3.3 Mexico: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)
10.1.6.3.4 Mexico: Virus-like Particles Market, by Source, 2019–2028 (US$ Mn)
10.1.6.3.5 Mexico: Virus-like Particles Market, by Application, 2019–2028 (US$ Mn)
10.2 Europe: Virus-like Particles Market
10.2.1 Overview
10.2.2 Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.3 Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
10.2.4 Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
10.2.5 Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.2.6 Europe: Virus-like Particles Market, by Country, 2021 & 2028(%)
10.2.6.1 Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.1.3 Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.1.4 Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
10.2.6.1.5 Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.2.6.2 France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.2.1 Overview
10.2.6.2.2 France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.2.3 France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.2.4 France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
10.2.6.2.5 France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.2.6.3 UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.3.3 UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.3.4 UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
10.2.6.3.5 UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.2.6.4 Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.4.3 Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.4.4 Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
10.2.6.4.5 Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.2.6.5 Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.5.3 Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.5.4 Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
10.2.6.5.5 Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.2.6.6 Rest of Europe: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.6.3 Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
10.2.6.6.4 Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
10.2.6.6.5 Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3 Asia Pacific Virus-like Particles Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.3 Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.4 Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
10.3.5 Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.3.6.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.1.1 Overview
10.3.6.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)
10.3.6.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)
10.3.6.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.2.1 Overview
10.3.6.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)
10.3.6.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.3.1 Overview
10.3.6.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.3.6.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
10.3.6.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
10.3.6.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4 Middle East & Africa Virus-like Particles Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.3 Middle East & Africa: Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)
10.4.4 Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
10.4.5 Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.4.6.1 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.1.3 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6.1.4 UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)
10.4.6.1.5 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.2.3 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6.2.4 Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)
10.4.6.2.5 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6.3 South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.3.3 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6.3.4 South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)
10.4.6.3.5 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6.4 Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
10.4.6.4.3 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.4.6.4.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)
10.4.6.4.5 Rest of Middle East and Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.5 South and Central America Virus-like Particles Market Revenue and Forecasts To 2028
10.5.1 Overview
10.5.2 South and Central America Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.3 South and Central America Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
10.5.4 South and Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
10.5.5 South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.5.6 South and Central America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.5.6.1 Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.6.1.3 Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
10.5.6.1.4 Brazil Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Mn)
10.5.6.1.5 Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.5.6.2 Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.6.2.3 Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
10.5.6.2.4 Argentina: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Mn)
10.5.6.2.5 Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
10.5.6.3 Rest of South and Central America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Mn)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Mn)
10.5.6.3.3 Rest of South & Central America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
10.5.6.3.4 Rest of South & Central America: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Mn)
10.5.6.3.5 Rest of South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
11. Impact Of COVID-19 Pandemic on Virus-like Particles Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South And Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Virus-like Particles Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Merck & Co., Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Dynavax Technologies
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Wantai BioPharm
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Serum Institute of India Pvt. Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BHARAT BIOTECH
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 LG Chem
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 VBI Vaccines Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 2. North America Virus-Like Particles Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 3. North America Virus-like Particles Market, by Application– Revenue and Forecast to 2028 (US$ Mn)
Table 4. US Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 5. US Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 6. US Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 7. Canada: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 8. Canada Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 9. Canada Virus-Like Particles Market, by Application – Revenue and Forecast to 2028 (US$ Mn)
Table 10. Mexico: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 11. Mexico Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 12. Mexico Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 13. Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 14. Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 15. Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 16. Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 17. Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 18. Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 19. France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 20. France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 21. France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 22. UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 23. UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 24. UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 25. Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 26. Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 27. Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 28. Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 29. Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 30. Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 31. Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)
Table 32. Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)
Table 33. Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 34. Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn).
Table 35. Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 36. Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 37. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)
Table 38. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)
Table 39. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 40. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 41. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)
Table 42. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 43. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 44. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 45. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 46. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 47. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 48. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 49. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 50. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 51. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 52. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 53. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 54. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 55. Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 56. Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 57. Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 58. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 59. UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 60. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 61. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 62. Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 63. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 64. South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)
Table 65. South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 66. South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 67. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 68. Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 69. Rest of Middle East and Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 70. South and Central America Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
Table 71. South and Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 72. South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 73. Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
Table 74. Brazil Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 75. Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 76. Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
Table 77. Argentina: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 78. Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 79. Rest of South & Central America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)
Table 80. Rest of South & Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)
Table 81. Rest of South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms: Virus-like Particles Market
LIST OF FIGURES
Figure 1. Virus-like particles Market Segmentation
Figure 2. Virus-like particles Market Segmentation, By Region
Figure 3. Global Virus-like Particles Market Overview
Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Virus-like particles Market
Figure 5. Asia Pacific to Show Significant Growth during Forecast Period
Figure 6. Virus-like Particles Market, by Geography (US$ Mn)
Figure 7. Global Virus-like Particles Market – Leading Country Markets (US$ Mn)
Figure 8. Global Virus-like Particles Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Virus-like Particles Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Virus-like Particles Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Global Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 18. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 19. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 20. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 21. Global Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 22. Yeast: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. Plant: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Insect Cell: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 25. Others: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Global Virus-like Particles Market Share, by Treatment, 2021 & 2028 (%)
Figure 27. Vaccine: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. Therapeutics: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 29. North America: Virus-like Particles Market, by Key Country – Revenue (2021) (US$ Mn)
Figure 30. North America Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 31. North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)
Figure 32. US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 33. Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 34. Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 35. Europe: Virus-like Particles Market, by Key Country – Revenue (2021) (USD Million)
Figure 36. Europe: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 37. Europe: Virus-like Particles Market, by Country, 2021 & 2028 (%)
Figure 38. Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 39. France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 40. UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 41. Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 42. Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 43. Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 44. Asia Pacific Virus-like Particles Market Overview, by Country (2021)
Figure 45. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 46. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 47. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 48. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 49. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 50. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 51. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 52. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)
Figure 53. Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 54. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 55. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 56. UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 57. Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 58. South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 59. Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)
Figure 60. South and Central America Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 61. South and Central America Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 62. South and Central America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 63. Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 64. Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 65. Rest of South and Central America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Mn)
Figure 66. Impact of COVID-19 Pandemic in North American Country Markets
Figure 67. Impact of COVID-19 Pandemic in European Country Markets
Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 69. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 70. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 71. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Virus-like Particles (VLP's) Market
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Dynavax Technologies
- Sanofi
- Wantai BioPharm
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- VBI Vaccines Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Virus-Like Particles Market
Nov 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2021